連携データベース 8 · 대한화장품협회 성분사전, 미국 EPA 화학물질 DB, 미국 EPA CompTox, 식약처 화장품 원료성분 +4
定義
Solvent naphtha (petroleum) heavy aromatic. A complex combination of hydrocarbons obtained from distillation of aromatic streams. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C12-15
이 원료는 평균 12-15개의 탄소원자로 구성된 곧은 사슬, 고리형 및 방향족 탄화수소의 혼합물이다.
出典: 식약처 화장품 원료성분
別名・識別情報
C12-15 ALKANE/CYCLOALKANE/AROMATIC HYDROCARBONSINCIC12-15알케인/사이클로알케인/아로마틱하이드로카본식약처 표준명Solvent naphtha (petroleum), heavy arom.동의어
- CAS No.化学物質登録番号
- 64742-94-5
- EC No.EU化学物質目録番号
- 265-198-5
- DTXSID米国EPA化学物質番号
- DTXSID9028251
化粧品での役割
다른 성분을 녹이는 바탕SOLVENT
安全性・規制情報
국내 유독물 GHS 분류 없음 · 기존화학물질
Other restriction: ban substances that deplete the ozone layer
出典: EU CosIng 성분 목록
製品が実際に使っている用途
미국 EPA에 이 성분을 신고한 제품 36건의 용도입니다. 화장품 밖의 제품도 포함되어 있어, 위쪽 몇 줄이 이 성분의 주된 쓰임으로 읽힌다는 뜻입니다.
- 용제16
- 공정 보조4
- 윤활제4
- 바인더2
- 계면활성제2
- 소포제2
- 연료 첨가2
- 점도 조절1
나머지 용도 3개
- 분산제1
- 연료1
- 유화 파괴1
出典: 미국 EPA CompTox
刺激・感作試験の記録
피부 시험 15건 · 눈 시험 8건이 기록되어 있습니다.
자극 높음으로 분류12건중간으로 분류1건낮음으로 분류18건
시험마다 결론이 갈립니다(가장 많은 결론의 비중 39%). 이 성분이 자극적이라고 단정할 수 없다는 뜻입니다. 원료 자체를 시험한 기록이고, 완제품에 든 농도에서의 자극성과는 다릅니다.
시험 23건 전부 보기
- Severe Irritation
skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) according to - Severe Irritation
skin irritation: in vivo · Screening · other guideline: EPA Guidelines in FR Vol. 44, No. 145, pgs 44054-44093 according to - Not likely to be sensitizing
skin sensitisation: in vivo (non-LLNA) · Screening · equivalent or similar to EPA OTS 798.4100 (Skin Sensitisation) - Not likely to be sensitizing
skin sensitisation: in vivo (non-LLNA) · Screening · according to other guideline: EPA guidelines in FR Vol. 44, No. 145, pgs. 44054-44093 - Not likely to be sensitizing
skin sensitisation: in vivo (non-LLNA) · Screening · according to other guideline: EPA guidelines in FR Vol. 44, No. 145, pgs 44054-44093 - Not likely to be sensitizing
skin sensitisation: in vivo (non-LLNA) · Screening · according to EPA OTS 798.4100 (Skin Sensitisation) equivalent or similar to OECD Guideline 406 (Skin Sensitisation) - Not likely to be sensitizing
skin sensitisation: in vivo (non-LLNA) · Screening · according to EPA OTS 798.4100 (Skin Sensitisation) - Studies Indicate No Significant Irritation
skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) according to - Severe Irritation
skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) according to EU Method B.4 (Acute Toxicity: Dermal Irritation / Corrosion) according to - Severe Irritation
skin irritation: in vivo · Screening · EPA OTS 798.4470 (Acute Dermal Irritation) according to - Category 2
Skin Irritation · Screening - Severe Irritation
skin irritation: in vivo · Screening · other guideline: EPA Guidelines in FR Vol. 44, No. 145, pgs. 44054-44093 according to - Studies Indicate No Significant Irritation
skin irritation: in vivo · Screening · EPA OTS 798.4470 (Acute Dermal Irritation) according to OECD Guideline 404 (Acute Dermal Irritation / Corrosion) equivalent or similar to - Classification not possible
Skin Sensitization · Screening - Studies Indicate No Significant Irritation
skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) according to EU Method B.4 (Acute Toxicity: Dermal Irritation / Corrosion) according to - Studies Indicate No Significant Irritation
eye irritation: in vivo · Screening · EPA OTS 798.4500 (Acute Eye Irritation) equivalent or similar to - Studies Indicate No Significant Irritation
eye irritation: in vivo · Screening · OECD Guideline 405 (Acute Eye Irritation / Corrosion) according to EU Method B.5 (Acute Toxicity: Eye Irritation / Corrosion) according to - Studies Indicate No Significant Irritation
eye irritation: in vivo · Screening · OECD Guideline 405 (Acute Eye Irritation / Corrosion) according to - Studies Indicate No Significant Irritation
eye irritation: in vivo · Screening · OECD Guideline 405 (Acute Eye Irritation / Corrosion) equivalent or similar to - Studies Indicate No Significant Irritation
eye irritation: in vivo · Screening · EU Method B.5 (Acute Toxicity: Eye Irritation / Corrosion) according to OECD Guideline 405 (Acute Eye Irritation / Corrosion) according to - Studies Indicate No Significant Irritation
eye irritation: in vivo · Screening · EPA OTS 798.4500 (Acute Eye Irritation) according to - Category 2
Eye Irritation · Screening - Studies Indicate No Significant Irritation
eye irritation: in vivo · Screening · other guideline: EPA Guidelines in FR Vol. 44, No. 145, pgs. 44054-44093 according to
出典: 미국 EPA CompTox